Prevention and Diagnosis of Severe T-Cell-Mediated Adverse Drug Reactions: Are We There Yet?

J Allergy Clin Immunol Pract. 2019 Jan;7(1):228-230. doi: 10.1016/j.jaip.2018.07.011.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Administration, Cutaneous
  • Drug Hypersensitivity*
  • HLA-B Antigens
  • Humans
  • Skin
  • T-Lymphocytes / immunology*

Substances

  • HLA-B Antigens